This document discusses Bipolar Disorders I and II as defined by the DSM-5. Bipolar I Disorder requires at least one manic episode, along with potential hypomanic or depressive episodes. Diagnostic criteria for manic, hypomanic, and depressive episodes are provided. Bipolar II Disorder involves at least one hypomanic and one depressive episode, without mania. It further defines hypomanic and depressive episode criteria and discusses the development, course, and age of onset for both disorders.
Schizophrenia Spectrum & Other Psychotic Disorders for NCMHCE StudyJohn R. Williams
Quick review of the essential points— DSM5 diagnosis criteria, assessments, treatments—of these disorders to better prepare for the National Clinical Mental Health Counseling Exam. This was informed by several exam prep programs, and can be used like flashcards or as a presentation.
Will talk about the severe psychological disorders-- The familiar name for all might be -"Schizophrenia" - it is not just one category but has multiple categories combined under -"Schizophrenia spectrum"
My forensic psychiatric research done in Indian jails shows most convicts under murder cases belong to schizophrenia spectrum (98% schizophrenia and 2% paranoid & schizoid personality disorders), and most have murdered their spouses, family members, friends or colleagues and surrendered themselves on the spot.
This presentation on the "Schizophrenia spectrum" has been particularly shared with you all to extend my message to help these affected people at the right time and maintaining their condition to prevent them from committing such crimes as there is no proper mental health care--Clinical, Legal or authoritative help available for convicts suffering from mental disorder.
Schizophrenia Spectrum & Other Psychotic Disorders for NCMHCE StudyJohn R. Williams
Quick review of the essential points— DSM5 diagnosis criteria, assessments, treatments—of these disorders to better prepare for the National Clinical Mental Health Counseling Exam. This was informed by several exam prep programs, and can be used like flashcards or as a presentation.
Will talk about the severe psychological disorders-- The familiar name for all might be -"Schizophrenia" - it is not just one category but has multiple categories combined under -"Schizophrenia spectrum"
My forensic psychiatric research done in Indian jails shows most convicts under murder cases belong to schizophrenia spectrum (98% schizophrenia and 2% paranoid & schizoid personality disorders), and most have murdered their spouses, family members, friends or colleagues and surrendered themselves on the spot.
This presentation on the "Schizophrenia spectrum" has been particularly shared with you all to extend my message to help these affected people at the right time and maintaining their condition to prevent them from committing such crimes as there is no proper mental health care--Clinical, Legal or authoritative help available for convicts suffering from mental disorder.
A presentation about depressive disorder. The presentation composed of the definition, causes, types, clinical feature, diagnosis, prognosis, treatment and prevention of depression
Schizophrenia is a chronic and severe mental disorder that affects how a person thinks, feels, and behaves. People with schizophrenia may seem like they have lost touch with reality. Although schizophrenia is not as common as other mental disorders, the symptoms can be very disabling.
10.30.08(a): Schizophrenia and other Psychotic DisordersOpen.Michigan
Slideshow is from the University of Michigan Medical
School's M2 Psychiatry sequence
View additional course materials on Open.Michigan: openmi.ch/med-M2Psych
Insight is one of the crucial components of a mental status examination in Psychiatry. Scarce data is available in the standard textbooks on this concept.
The following presentation was made after going through the myriad of articles and case studies i found online.
A presentation about depressive disorder. The presentation composed of the definition, causes, types, clinical feature, diagnosis, prognosis, treatment and prevention of depression
Schizophrenia is a chronic and severe mental disorder that affects how a person thinks, feels, and behaves. People with schizophrenia may seem like they have lost touch with reality. Although schizophrenia is not as common as other mental disorders, the symptoms can be very disabling.
10.30.08(a): Schizophrenia and other Psychotic DisordersOpen.Michigan
Slideshow is from the University of Michigan Medical
School's M2 Psychiatry sequence
View additional course materials on Open.Michigan: openmi.ch/med-M2Psych
Insight is one of the crucial components of a mental status examination in Psychiatry. Scarce data is available in the standard textbooks on this concept.
The following presentation was made after going through the myriad of articles and case studies i found online.
Quick review of the essential points— DSM5 diagnosis criteria, assessments, treatments—of these disorders to better prepare for the National Clinical Mental Health Counseling Exam. This can be used like flashcards or as a presentation.
Quick review of the essential points— DSM5 diagnosis criteria, assessments, treatments—of these disorders to better prepare for the National Clinical Mental Health Counseling Exam. This was informed by several exam prep programs, and can be used like flashcards or as a presentation.
Bipolar disorders in DSM-5: strengths, problems and perspectivesLena Setianingsih
International Journal of Bipolar Disorders
Bipolar disorders in DSM-5: strengths, problems and perspective
Source :http://www.journalbipolardisorders.com/content/1/1/12
Quick review of the essential points— DSM5 diagnosis criteria, assessments, treatments—of these disorders to better prepare for the National Clinical Mental Health Counseling Exam. This can be used like flashcards or as a presentation.
The recognition of bipolar disorder in primary careNick Stafford
Bipolar disorder and the complexities of screening and diagnosis in primary care. How more accurate detection and an integrated care pathway with secondary care can improve the diagnosis and outcome of the treatment of the disorder.
Bipolar depression: Diagnosis and TreatmentScott Eaton
Differentiating Depression in Bipolar Affective Disorder, Unipolar Depression and Borderline Personality Disorder.
How to treat this depression following the new CANMAT 2013 guidelines.
Depression is the leading cause of disability world wide and is a major contributor to the overall global burden of diseases .At its worst depression can cause suicide .
There are effective psychological and pharmacological treatments for depression
BEATING THE BLUES: PRACTICAL SOLUTIONS FOR A COMMON HEALTH PROBLEMSummit Health
Lecture on depression, including information about causes, symptoms, and treatment. Learn to distinguish depression from feeling down. Find out how practical techniques can help improve short-term and long-term blue moods, sadness, and depression.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
4. Bipolar I Disorder
Prevalence (APA, 2013):
• 12-month prevalence estimate in US is 0.6%
• Lifetime male-to-female ratio is 1.1:1
5. Bipolar I Disorder Cont.
Diagnostic Criteria (APA, 2013):
• At least one lifetime manic episode required for
diagnosis
• Manic episode may be preceded/followed by hypomanic
or major depressive episode
• Specific criteria must be met for a current/past
hypomanic episode and current/past major depressive
episode
6. Bipolar I Disorder Cont.
Manic Episode (APA, 2013):
• Distinct period of abnormally and persistently elevated,
expansive, or irritable mood
• Increased energy or activity
• Lasting at least 1 week and present most of the day,
nearly every day
7. Bipolar I Disorder Cont.
Manic Episode cont. (APA, 2013):
• 3 or more of the following (4 if mood is only irritable):
• Inflated self-esteem or grandiosity
• Decreased need for sleep
• More talkative than usual
• Flight of ideas
• Distractibility
• Increase in goal-directed activity
• Excessive involvement in risk taking activities
• Spending sprees
• Sexual indiscretions
8. Bipolar I Disorder Cont.
Manic Episode cont. (APA, 2013):
• Mood disturbance is severe to cause marked impairment
in social/occupational functioning or requires
hospitalization
• Episode not attributable to the physiological effects of a
substance or another medical condition
9. Bipolar I Disorder Cont.
Hypomanic Episode (APA, 2013):
• Distinct period of abnormally and persistently elevated,
expansive, or irritable mood
• Increased activity or energy
• Lasting at least 4 consecutive days and present most of
the day, nearly every day
10. Bipolar I Disorder Cont.
Hypomanic Episode cont. (APA, 2013):
• 3 or more of the following (4 if mood is only irritable):
• Inflated self-esteem or grandiosity
• Decreased need for sleep
• More talkative than usual
• Flight of ideas
• Distractibility
• Increase in goal-directed activity
• Excessive involvement in risk taking activities
• Spending sprees
• Sexual indiscretions
11. Bipolar I Disorder Cont.
Hypomanic Episode cont. (APA, 2013):
• Episode associated with change in functioning
• Uncharacteristic when asymptomatic
• Disturbance in mood/change in functioning observed by
others
• Not severe enough to cause impairment in
social/occupational functioning
• Not requiring hospitalization
• Not attributable to the physiological effects of a
substance
• Are common in bipolar I but not required for diagnosis
12. Bipolar I Disorder Cont.
Major Depressive Disorder (APA, 2013):
• 5 or more of the following symptoms during the same 2-
week period and represent change from prior
functioning:
• 1 symptom must be (1) depressed mood or (2) loss of
interest/pleasure
• Depressed mood most of the day, nearly every day per subjective
report or observation
• Diminished interest, pleasure in all, or most, activities
• Significant weight-loss or weight-gain
• Insomnia or hypersomnia
• Psychomotor agitation
• Fatigue
13. Bipolar I Disorder Cont.
Major Depressive Disorder cont. (APA, 2013):
• Feelings of worthlessness
• Diminished ability to think/concentrate
• Recurrent thoughts of death, suicidal ideation
• Symptoms cause clinically significant distress/impairment
in social, occupational functioning
• Not attributable to the physiological effects of a
substance or another medication
• Are common in bipolar I but not required for diagnosis
14. Bipolar I Disorder Cont.
Development and Course (APA, 2013):
• Mean age of onset: 18 years
• Onset may occur throughout the life cycle
• Manic symptoms later in life may indicate medical conditions
• > 90% of individuals who have 1 episode experience
recurrent
• Approx. 60% of manic episodes occur immediately
before a major depressive episode
• Rapid cycling occurs when individuals experience 4 or
more mood episodes in 1 year
15. Bipolar I Disorder Cont.
Functional Consequences (APA, 2013):
• Approx. 30% of individuals experience severe
impairment in work role function
• Functional recovery may be slow
• Cognitive impairments may occur
Cultural issues (APA, 2013):
• Little data exists on specific cultural differences
• Lack of transcultural validation
• One U.S. study shows 12-month prevalence significantly lower
in Afro-Caribbeans than African Americans and Whites
16. Bipolar I Disorder Cont.
Measurements (STABLE, 2007):
• The Mood Disorder Questionnaire (MDQ)
• Screening tool: present and past episodes of mania/hypomania.
• Includes 13 questions associated with the symptoms of bipolar
disorder
• Plus items assessing clustering of symptoms and functional
impairment
• May be used in primary care settings
• Efficient way to identify patients most likely to have a bipolar
disorder
17. Bipolar I Disorder Cont.
Measurements cont. (STABLE, 2007):
• The Composite International Diagnostic Interview (CIDI)
Bipolar Disorder Screening Scale
• Can accurately identify threshold/sub-threshold bipolar disorder
• Scale detected between 67-96% of true cases in clinical studies
• Compares favorably with the MDQ screening scale
18. Bipolar I Disorder Cont.
Diagnostic Features (APA, 2013):
• Manic Episode:
• Euphoric: “feeling on top
of the world”
• Increased activity
• Irritable
• Grandiose delusions
• Decreased need for sleep
• Rapid, pressured speech
• Racing thoughts
• Distractibility
• Marked impairment in
social/occupational
function
• Rapidly shifting mood to
anger or depression
• Depressive symptoms may
occur during a manic
episode
19. Brief I Disorder Cont.
Specifiers (APA, 2013):
• With anxious distress
• With mixed features
• With rapid cycling
• With melancholic
features
• With atypical features
• With mood-congruent
psychotic features
• With mood-incongruent
psychotic features
• With catatonia
• With peripartum onset
• With seasonal pattern
20. Bipolar I Disorder Cont.
ICD-10 Coding and severity (APA, 2013):
Bipolar I
disorder
Current/most recent
episode manic
Current/most recent
episode hypomanic*
Current/most recent
episode depressed
Current/most recent
episode unspecified**
Mild 296.41
(F31.11)
NA 296.51
(F31.31)
NA
Moderate 296.42
(F31.12)
NA 296.52
(F31.32)
NA
Severe 296.43
(F31.13)
NA 296.53
(F31.4)
NA
With psychotic
features***
296.44
(F31.2)
NA 296.54
(F31.5)
NA
In partial
remission
296.45
(F31.73)
296.45
(F31.73)
296.55
(F31.75)
NA
In full
remission
296.46
(F31.74)
296.46
(F31.74)
296.56
(F31.76)
NA
Unspecified 296.40
(F31.9)
296.40
(F31.9)
296.50
(F31.9)
NA
*Severity & psychotic specifiers do not apply; code 296.40 (F31.0) for cases not in remission.
**Severity, psychotic, and remission specifiers do not apply; code 296.7 (F31.9).
21. Bipolar I Disorder Cont.
Differential Diagnoses (APA, 2013):
• Major depressive disorder
• Other bipolar disorders
• Generalized anxiety disorder, panic disorder,
posttraumatic stress disorder, or other anxiety disorders
• Substance/medication-induced bipolar disorder
• Attention-deficit/hyperactivity disorder
• Personality disorders
• Disorders with prominent irritability
22. Bipolar II Disorder
Prevalence (APA, 2013):
• 12-month prevalence estimate in US is 0.8%
• Internationally 0.3%
Diagnostic Criteria (APA, 2013):
• One hypomanic and one major depressive episode
• Never experienced a manic episode
• Specific criteria must be met for a current/past
hypomanic episode and current/past major depressive
episode:
23. Bipolar II Disorder Cont.
Hypomanic Episode (APA, 2013):
• Distinct period of abnormally and persistently
elevated, expansive, or irritable mood
• Increased activity or energy
• Lasting at least 4 consecutive days and present most of
the day, nearly every day
24. Bipolar II Disorder Cont.
Hypomanic Episode cont. (APA, 2013):
• 3 or more of the following (4 if mood is only irritable):
• Inflated self-esteem or grandiosity
• Decreased need for sleep
• More talkative than usual
• Flight of ideas
• Distractibility
• Increase in goal-directed activity
• Excessive involvement in risk taking activities
• Spending sprees
• Sexual indiscretions
25. Bipolar II Disorder Cont.
Hypomanic Episode cont. (APA, 2013):
• Episode associated with change in functioning
• uncharacteristic when asymptomatic
• Disturbance in mood and change in functioning observed
by others
• Not severe enough to cause impairment in
social/occupational functioning
• Not requiring hospitalization
• Not attributable to the physiological effects of a
substance
26. Bipolar II Disorder Cont.
Major Depressive Disorder (APA, 2013):
• 5 or more of the following symptoms during the same 2-
week period and represent change from prior
functioning:
• 1 symptom must be (1) depressed mood or (2) loss of
interest/pleasure
• Depressed mood most of the day, nearly every day per subjective
report or observation
• Diminished interest, pleasure in all, or most, activities
• Significant weight-loss or weight-gain
• Insomnia or hypersomnia
• Psychomotor agitation
• Fatigue
27. Bipolar II Disorder Cont.
Major Depressive Disorder cont. (APA, 2013):
• Feelings of worthlessness
• Diminished ability to think/concentrate
• Recurrent thoughts of death, suicidal ideation
• Symptoms cause clinically significant distress/impairment
in social, occupational functioning
• Not attributable to the physiological effects of a
substance or another medication
28. Bipolar II Disorder Cont.
Development and Course (APA, 2013):
• Can begin in late adolescence
• Average age of onset in mid-20s
• Slightly later than bipolar I
• Most often begins with depressive episode and not
recognized until hypomanic episode occurs
• May be preceded by anxiety, substance use, or eating
disorders
• Lifetime episodes of hypomanic and depressive episodes
greater than in bipolar I
29. Bipolar II Disorder Cont.
Functional Consequences (APA, 2013):
• Most individuals return to fully functional state between
episodes
• 15% may continue to have some inter-episode
dysfunction
• 20% transition directly into another mood episode
without inter-episode recovery
• Functional recovery may be slow
• Cognitive impairments may occur
30. Bipolar II Disorder Cont.
Cultural Issues (APA, 2013):
• Little data exists on specific cultural differences
• Lack of transcultural validation
31. Bipolar II Disorder Cont.
Measurements (STABLE, 2007):
• The Mood Disorder Questionnaire (MDQ)
• Screening tool: present and past episodes of mania/hypomania.
• Includes 13 questions associated with the symptoms of bipolar
disorder
• Plus items assessing clustering of symptoms and functional
impairment
• May be used in primary care settings
• Efficient way to identify patients most likely to have a bipolar
disorder
32. Bipolar II Disorder Cont.
Measurements cont. (STABLE, 2007):
• The Composite International Diagnostic Interview (CIDI)
Bipolar Disorder Screening Scale
• Can accurately identify threshold/sub-threshold bipolar disorder
• Scale detected between 67-96% of true cases in clinical studies
• Compares favorably with the MDQ screening scale
33. Bipolar II Disorder Cont.
Diagnostic Features (APA, 2013):
• Recurring mood episodes:
• 1 or more major depressive episodes
• Episode lasting at least 2 weeks
• At least 1 hypomanic episode
• Episode lasting at least 4 days
• During episode(s), required number of symptoms must be
present most of the day, nearly every day
• A manic episode precludes the diagnosis of bipolar II
• Individuals typically present for treatment during major
depressive episode
34. Bipolar II Disorder Cont.
Specifiers and Severity(APA, 2013):
• Specify current or most recent episode:
• Hypomanic
• Depressed
• Specify if (APA, 2013):
• With anxious distress
• With mixed features
• With rapid cycling
• With mood-congruent psychotic features
• With mood-incongruent psychotic features
• With catatonia
• With peripartum onset
• With seasonal pattern
35. Bipolar II Disorder Cont.
• Specify course if full criteria for a mood episode not
currently met (APA, 2013):
• In partial remission
• In full remission
• Specify severity if full criteria for a mood episode are
currently met (APA, 2013):
• Mild
• Moderate
• Severe
36. Bipolar II Disorder Cont.
Differential diagnoses (APA, 2013):
• Major depressive disorder
• Cyclothymic disorder
• Schizophrenia spectrum and other related psychotic
disorders
• Panic disorder or other related anxiety disorders
• Substance use disorders
• Attention-deficit/hyperactivity disorder
• Personality disorders
• Other bipolar disorders
37. Bipolar II Disorder Cont.
ICD-10 (APA, 2013, p. 111):
• Bipolar II disorder has only one diagnostic code:
• 296.89 (F31.81)
• Severity, presence of psychotic features, course, and other
specifiers cannot be coded but should be indicated in writing
38. Differences Between Bipolar I & II
Bipolar I
• At least 1 manic or mixed
episode
Bipolar II
• Never had a manic episode
• At least 1 hypomanic episode
• At least 1 major depressive
episode
44. Case Study Cont.
Did you recognize the symptoms of Bipolar I Disorder?
• Mania:
• Insomnia
• Rapid speech
• Euphoria
• Intermittent irritability
• Hospitalized for a previous manic episode
• Depression 2 months prior and treated with SSRI
• Antidepressants can worsen mania and cause rapid cycling
• Rapid cycling
46. References
American Psychiatric Association. (2013). Clinician-rated
dimensions of psychosis symptom severity. Retrieved
from http://www.psychiatry.org /File%20Library/
Practice/DSM/DSM-5/ClinicianRatedDimensionsOf
PsychosisSymptomSeverity.pdf
American Psychiatric Association. (2013). Diagnostic and
statistical manual of mental disorders (5th ed.).
Washington D.C.: Author.
Epocrates. (2015). Bipolar disorder in adults. Retrieved from
https://online.epocrates.com/u/2942488/Bipolar+disord
er+in+adults/Treatment/Tx+Details
47. References Cont.
Novac, A. (1998). Atypical antipsychotics as enhancement
therapy in rapid cycling mood states: A case study.
Retrieved from http://link.springer.com/article/
10.1023/A%3A1022398104353
Stable National Coordinating Council. (2007). Stable resource
toolkit. Retrieved from http://www.integration.
samhsa.gov/images/res/STABLE_toolkit.pdf